No Data
No Data
Needham Downgrades Cogent Biosciences to Hold, Maintains Price Target to $15
Express News | Cogent Biosciences Inc : Needham Cuts to Hold From Buy
Needham Downgrades Cogent Biosciences(COGT.US) to Hold Rating, Maintains Target Price $15
H.C. Wainwright Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $17
Cogent Biosciences Price Target Maintained With a $15.00/Share by Needham
Cogent Biosciences Analyst Ratings
No Data